Yoshiki Miyata

634 total citations
19 papers, 573 citations indexed

About

Yoshiki Miyata is a scholar working on Molecular Biology, Plant Science and Cancer Research. According to data from OpenAlex, Yoshiki Miyata has authored 19 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Plant Science and 6 papers in Cancer Research. Recurrent topics in Yoshiki Miyata's work include Bioactive Compounds in Plants (11 papers), Phytochemical compounds biological activities (6 papers) and Protease and Inhibitor Mechanisms (6 papers). Yoshiki Miyata is often cited by papers focused on Bioactive Compounds in Plants (11 papers), Phytochemical compounds biological activities (6 papers) and Protease and Inhibitor Mechanisms (6 papers). Yoshiki Miyata collaborates with scholars based in Japan, Spain and China. Yoshiki Miyata's co-authors include Takashi Sato, Akira Itô, Masamichi Yano, Hiroshi Kosano, Arata Shimada, Yutaka Sashida, Yoshihiro Mimaki, Michiko Hirata, Haruyuki Tanaka and Toshikazu Yamanouchi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and Molecular Cancer Therapeutics.

In The Last Decade

Yoshiki Miyata

17 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiki Miyata Japan 12 299 293 205 112 72 19 573
Bong Hwan Park South Korea 15 320 1.1× 89 0.3× 99 0.5× 66 0.6× 43 0.6× 20 792
Wuliji Ao China 13 312 1.0× 168 0.6× 58 0.3× 51 0.5× 28 0.4× 49 526
Julia Lawrence United States 8 368 1.2× 64 0.2× 118 0.6× 64 0.6× 84 1.2× 10 664
Suresh R. Volate United States 10 383 1.3× 93 0.3× 129 0.6× 58 0.5× 55 0.8× 11 757
Kader Turkekul Türkiye 12 359 1.2× 65 0.2× 72 0.4× 138 1.2× 108 1.5× 15 691
Yue Guo China 9 330 1.1× 104 0.4× 84 0.4× 40 0.4× 50 0.7× 14 534
Rong-Tsun Wu Taiwan 11 195 0.7× 135 0.5× 54 0.3× 40 0.4× 35 0.5× 14 445
Junzhi Wang China 17 378 1.3× 97 0.3× 52 0.3× 109 1.0× 53 0.7× 51 676
Cheng‐Le Yin Hong Kong 14 342 1.1× 136 0.5× 55 0.3× 89 0.8× 53 0.7× 28 616
Shumaila Tasneem China 8 237 0.8× 122 0.4× 38 0.2× 54 0.5× 24 0.3× 14 480

Countries citing papers authored by Yoshiki Miyata

Since Specialization
Citations

This map shows the geographic impact of Yoshiki Miyata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiki Miyata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiki Miyata more than expected).

Fields of papers citing papers by Yoshiki Miyata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiki Miyata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiki Miyata. The network helps show where Yoshiki Miyata may publish in the future.

Co-authorship network of co-authors of Yoshiki Miyata

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiki Miyata. A scholar is included among the top collaborators of Yoshiki Miyata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiki Miyata. Yoshiki Miyata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Takemoto, Yasushi, et al.. (2025). Side-Chain Fluorine Engineering of Vitamin D<sub>3</sub> Derivatives for VDR-Silent SREBP Inhibitors. Chemical and Pharmaceutical Bulletin. 73(9). 868–883.
2.
Otake, Hiroko, Tetsushi Yamamoto, Yoshiki Miyata, et al.. (2024). Semiquantitative analysis of protein expression in heated rat lens using shotgun proteomics. Molecular Medicine Reports. 31(1).
3.
Kusakabe, Yoshio, et al.. (2023). Isolation and identification of the new baicalin target protein to develop flavonoid structure-based therapeutic agents. Bioorganic & Medicinal Chemistry. 90. 117362–117362. 2 indexed citations
8.
Shimada, Arata, Yoshiki Miyata, & Hiroshi Kosano. (2014). Type I Collagen Accelerates the Spreading of Lens Epithelial Cells through the Expression and Activation of Matrix Metalloproteinases. Current Eye Research. 39(5). 460–471. 11 indexed citations
9.
Miyata, Yoshiki, et al.. (2013). Cell-mediated contraction of vitreous explants from chicken embryo: possibility of screening for therapeutic agents against proliferative vitreoretinal diseases.. PubMed. 19. 2374–84. 2 indexed citations
10.
11.
Miyata, Yoshiki, Tetsuta Oshitari, Arata Shimada, et al.. (2012). Polymethoxyflavones as agents that prevent formation of cataract: Nobiletin congeners show potent growth inhibitory effects in human lens epithelial cells. Bioorganic & Medicinal Chemistry Letters. 23(1). 183–187. 15 indexed citations
12.
Oshitari, Tetsuta, et al.. (2011). Nobiletin metabolites: Synthesis and inhibitory activity against matrix metalloproteinase-9 production. Bioorganic & Medicinal Chemistry Letters. 21(15). 4540–4544. 25 indexed citations
13.
Miyata, Yoshiki, Haruyuki Tanaka, Arata Shimada, et al.. (2011). Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin. Life Sciences. 88(13-14). 613–618. 95 indexed citations
14.
Oshitari, Tetsuta, et al.. (2011). B-Ring-modified and/or 5-demethylated nobiletin congeners: Inhibitory activity against pro-MMP-9 production. Bioorganic & Medicinal Chemistry. 19(23). 7085–7092. 15 indexed citations
15.
Miyata, Yoshiki, Takashi Sato, Keisuke Imada, et al.. (2007). A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochemical and Biophysical Research Communications. 366(1). 168–173. 80 indexed citations
16.
Miyata, Yoshiki, Takashi Sato, & Akira Itô. (2005). Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells. Biochemical and Biophysical Research Communications. 336(4). 1081–1086. 32 indexed citations
18.
Miyata, Yoshiki, Takashi Sato, Masamichi Yano, & Akira Itô. (2004). Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin.. PubMed. 3(7). 839–47. 54 indexed citations
19.
Sato, Takashi, Yoshiki Miyata, Michiko Hirata, et al.. (2002). Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells.. PubMed. 62(4). 1025–9. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026